← The Wire
KODNasdaq
Kodiak Sciences Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 1468748
Develops and commercializes next-generation retinal therapeutics using its Antibody Biopolymer Conjugate platform
$2.13B
Market cap
$37.74
Last close
+5.0%
1D
+3.0%
5D
941K
Volume
Price · last 39 sessions-10.7%
May 4L $29.61 · H $45.89Jun 29
131
Total filings
Jun 4, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 4, 202610-Q10-QMay 7, 20268-KResults of OperationsMay 7, 2026DEFA14ADEFA14AApr 22, 2026DEF 14ADEF 14AApr 22, 202610-K10-KMar 31, 20268-KResults of OperationsMar 31, 20268-KCompany UpdateMar 27, 2026SC 13D/ASC 13D/ADec 19, 20258-KCompany UpdateDec 18, 2025424B5424B5Dec 17, 2025424B5424B5Dec 15, 202510-Q10-QNov 13, 20258-KResults of OperationsNov 13, 202510-Q10-QAug 13, 20258-KResults of OperationsAug 13, 20258-KShareholder VoteJun 3, 202510-Q10-QMay 14, 20258-KResults of OperationsMay 14, 2025DEFA14ADEFA14AApr 22, 2025DEF 14ADEF 14AApr 22, 202510-K10-KMar 27, 20258-KResults of OperationsMar 27, 202510-Q10-QNov 14, 20248-KResults of OperationsNov 14, 202410-Q10-QAug 14, 20248-KResults of OperationsAug 14, 20248-KShareholder VoteJun 6, 202410-Q10-QMay 15, 20248-KResults of OperationsMay 15, 2024DEFA14ADEFA14AApr 23, 2024DEF 14ADEF 14AApr 23, 202410-K10-KMar 28, 20248-KResults of OperationsMar 28, 202410-Q10-QNov 14, 20238-KResults of OperationsNov 14, 20238-KCompany UpdateNov 6, 20238-KExecutive ChangeAug 17, 202310-Q10-QAug 14, 20238-KResults of OperationsAug 14, 20238-KResults of Operations · Company UpdateJul 24, 20238-KShareholder VoteJun 7, 202310-Q10-QMay 15, 20238-KResults of OperationsMay 15, 2023DEFA14ADEFA14AApr 25, 2023DEF 14ADEF 14AApr 25, 202310-K10-KMar 28, 20238-KResults of OperationsMar 28, 2023SC 13GSC 13GFeb 3, 202310-Q10-QNov 9, 20228-KResults of OperationsNov 9, 202210-Q10-QAug 9, 20228-KResults of OperationsAug 9, 20228-KCompany UpdateAug 8, 20228-KShareholder VoteJun 8, 20228-KResults of OperationsMay 10, 202210-Q10-QMay 10, 2022DEFA14ADEFA14AApr 28, 2022DEF 14ADEF 14AApr 28, 202210-K10-KMar 1, 20228-KResults of OperationsMar 1, 20228-KResults of Operations · Company UpdateFeb 23, 202210-Q10-QNov 9, 20218-KResults of OperationsNov 9, 20218-KExecutive Change · Shareholder VoteOct 15, 2021DEFA14ADEFA14AOct 5, 2021DEF 14ADEF 14ASep 13, 2021DEFA14ADEFA14ASep 1, 20218-KCompany UpdateSep 1, 202110-Q10-QAug 9, 20218-KResults of OperationsAug 9, 20218-KMaterial AgreementJul 23, 20218-KShareholder VoteJun 8, 202110-Q10-QMay 10, 20218-KResults of OperationsMay 10, 2021DEFA14ADEFA14AApr 28, 2021DEF 14ADEF 14AApr 28, 202110-K10-KMar 1, 20218-KResults of OperationsMar 1, 2021SC 13GSCHEDULE 13GFeb 10, 2021
Insider Activity
In the 90 days to Dec 18, 2025: 1 insider bought $60.0M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 18, 2025 | Baker Brothers Life Sciences LpDirector,TenPercentOwner | Buy | 2,391,268 | $23.00 | $55.0M |
| Dec 18, 2025 | Baker Brothers Life Sciences LpDirector,TenPercentOwner | Buy | 217,428 | $23.00 | $5.0M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance